Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Neven

Showing results (71-80 of 140) with videos related to

Pageof 14
Sort By:
Oncogene|March 18, 2008
Expression of the BRCA1-interacting protein Brip1/BACH1/FANCJ is driven by E2F and correlates with human breast cancer malignancyG Eelen, I Vanden Bempt, L Verlinden, et al.
Maturitas|June 11, 2016
Coping with menopausal symptoms: An internet survey of Belgian postmenopausal womenH Depypere, A Pintiaux, J Desreux, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 2000
The immunocytochemical versus cytosol measurement of the oestrogen receptor in invasive breast cancer tissueS L Gordts, P Neven, I Van Hooff, et al.
Breast (Edinburgh, Scotland)|April 10, 2013
The prognostic role of preoperative and (early) postoperatively change in CA15.3 serum levels in a single hospital cohort of primary operable breast cancersO Brouckaert, A Laenen, H Wildiers, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 10, 1998
Pyridothiadiazinedioxides structurally related to quinazolinones cholecystokinin/gastrin receptor ligands: synthesis and biological evaluationB Pirotte, P de Tullio, T Podona, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 7, 2010
Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST StudyH Eidtmann, R de Boer, N Bundred, et al.
Journal of Clinical Pathology|May 27, 2005
Association between tumour characteristics and HER-2/neu by immunohistochemistry in 1362 women with primary operable breast cancerH J Huang, P Neven, M Drijkoningen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 12, 2013
Genetic variability in the multidrug resistance associated protein-1 (ABCC1/MRP1) predicts hematological toxicity in breast cancer patients receiving (neo-)adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide (FEC)C Vulsteke, D Lambrechts, A Dieudonné, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 22, 2001
Evaluation of classical NSAIDs and COX-2 selective inhibitors on purified ovine enzymes and human whole bloodX de Leval, J Delarge, P Devel, et al.
Cardiovascular Drug Reviews|August 3, 2001
Pharmacology of the thromboxane receptor antagonist and thromboxane synthase inhibitor BM-531J M Dogné, S Rolin, X de Leval, et al.
Pageof 14

Showing results (71-80 of 140) with videos related to

Sort By:
Pageof 14
Oncogene|March 18, 2008
Expression of the BRCA1-interacting protein Brip1/BACH1/FANCJ is driven by E2F and correlates with human breast cancer malignancyG Eelen, I Vanden Bempt, L Verlinden, et al.
Maturitas|June 11, 2016
Coping with menopausal symptoms: An internet survey of Belgian postmenopausal womenH Depypere, A Pintiaux, J Desreux, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 2000
The immunocytochemical versus cytosol measurement of the oestrogen receptor in invasive breast cancer tissueS L Gordts, P Neven, I Van Hooff, et al.
Breast (Edinburgh, Scotland)|April 10, 2013
The prognostic role of preoperative and (early) postoperatively change in CA15.3 serum levels in a single hospital cohort of primary operable breast cancersO Brouckaert, A Laenen, H Wildiers, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 10, 1998
Pyridothiadiazinedioxides structurally related to quinazolinones cholecystokinin/gastrin receptor ligands: synthesis and biological evaluationB Pirotte, P de Tullio, T Podona, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 7, 2010
Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST StudyH Eidtmann, R de Boer, N Bundred, et al.
Journal of Clinical Pathology|May 27, 2005
Association between tumour characteristics and HER-2/neu by immunohistochemistry in 1362 women with primary operable breast cancerH J Huang, P Neven, M Drijkoningen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 12, 2013
Genetic variability in the multidrug resistance associated protein-1 (ABCC1/MRP1) predicts hematological toxicity in breast cancer patients receiving (neo-)adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide (FEC)C Vulsteke, D Lambrechts, A Dieudonné, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 22, 2001
Evaluation of classical NSAIDs and COX-2 selective inhibitors on purified ovine enzymes and human whole bloodX de Leval, J Delarge, P Devel, et al.
Cardiovascular Drug Reviews|August 3, 2001
Pharmacology of the thromboxane receptor antagonist and thromboxane synthase inhibitor BM-531J M Dogné, S Rolin, X de Leval, et al.
Pageof 14